scholarly journals Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial

Diabetes Care ◽  
2016 ◽  
Vol 39 (9) ◽  
pp. 1579-1586 ◽  
Author(s):  
Julio Rosenstock ◽  
Michaela Diamant ◽  
Vanita R. Aroda ◽  
Louise Silvestre ◽  
Elisabeth Souhami ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Randomized Trial ◽  
Fixed Ratio ◽  
Proof Of Concept ◽  
Efficacy And Safety ◽  
Metformin Monotherapy

scholarly journals Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes

2019 ◽  
Vol 21 (7) ◽  
pp. 1615-1624 ◽  
Author(s):  
David Russell‐Jones ◽  
Arnaud Dauchy ◽  
Elías Delgado ◽  
George Dimitriadis ◽  
Hans A. Frandsen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Randomized Trial ◽  
Efficacy And Safety

scholarly journals Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes

2019 ◽  
Vol 33 (3) ◽  
pp. 236-242 ◽  
Author(s):  
Yehuda Handelsman ◽  
Christina Chovanes ◽  
Terry Dex ◽  
Francesco Giorgino ◽  
Neil Skolnik ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Older Adults ◽  
Insulin Glargine ◽  
Fixed Ratio ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document